| 摘要 |
The invention relates to a combination which comprises a DPP-IV inhibitor an d at least one further PPAR.alpha. compound, preferably selected from the grou p consisting of fenofibrate, micronized fenofibrate, bezafibrate, gemfibrazil and ciprofibrate for simultaneous, separate or sequential use in the prevention, delay of progression or treatment of conditions mediated by DPP- IV and PPAR.alpha., in particular diabetes, more especially type 2 diabetes mellitus, conditions of IGT, conditions of impaired fasting plasma glucose, metabolic acidosis, ketosis, arthritis, obesity, dyslipidemia and osteoporos is.
|
